Clinical Trials Browser

Phase 2 × Unknown × HR+/HER2- Breast Cancer × Clear all

NCT05633914 2023-02-21

Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer

Phase 2 Unknown

HR+/HER2- Breast Cancer